Citations (47)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Daniel Turner, Peer Briken, Joshua Grubbs, Leo Malandain, Gemma Mestre-Bach, Marc N. Potenza & Florence Thibaut. (2022) The World Federation of Societies of Biological Psychiatry guidelines on the assessment and pharmacological treatment of compulsive sexual behaviour disorder. Dialogues in Clinical Neuroscience 24:1, pages 10-69.
Read now
Read now
Florence Thibaut, Abdeslam Chagraoui, Leslie Buckley, Florence Gressier, Javier Labad, Sandrine Lamy, Marc N. Potenza, Susan G. Kornstein, Marta Rondon, Anita Riecher-Rössler, Michael Soyka & Kim Yonkers. (2019) WFSBP and IAWMH Guidelines for the treatment of alcohol use disorders in pregnant women. The World Journal of Biological Psychiatry 20:1, pages 17-50.
Read now
Read now
Articles from other publishers (45)
Julian Wellensiek, Michael Specka, Johannes Just, Markus Banger, Udo Bonnet & Norbert Scherbaum. (2023) Patient Perspectives on Pharmacotherapy of Alcohol
Dependence. Pharmacopsychiatry.
Crossref
Crossref
Tsutomu Kurata, Tasuku Hashimoto, Hitoshi Suzuki, Minoru Ishige & Shuichi Kikuchi. (2023) Effect of a multidisciplinary approach on hospital visit continuation in the treatment of patients with alcohol dependence. Neuropsychopharmacology Reports.
Crossref
Crossref
M Claire Greene, Jeremy Kane, Michelle Alto, Ali Giusto, Kathryn Lovero, Melissa Stockton, Jasmine McClendon, Terriann Nicholson, Milton L. Wainberg, Renee M Johnson & Wietse Anton Tol. (2023) Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low- and middle-income countries. Cochrane Database of Systematic Reviews 2023:5.
Crossref
Crossref
Creeshen P. Muddapah & Lize Weich. (2023) Assessing the revised Clinical Institute Withdrawal for Alcohol Scale use at Stikland Hospital. South African Journal of Psychiatry 29.
Crossref
Crossref
Mir Faeq Quadri, Joanne Lusher, Morenike Folayan, Maha El Tantawi, Ariel Zuñiga, Brandon Brown, Nourhan Aly, Joseph Okeibunor, Giuliana Florencia, Mohammed Jafer, Eshrat Ara, Kessketlen Miranda, Nuraldeen Al-Khanati, Passent Ellakany, Balgis Gaffar, Anthonia Ishabiyi, Abeedha Khan, Zumama Khalid, Folake Lawal, Ntombifuthi Nzimande, Anas Shamala, Ala’a Al-Tammemi, Bamidele Osamika, Muhammad Yousaf, Jorma Virtanen & Annie Nguyen. (2023) Factors associated with an increase in alcohol consumption
and tobacco use during the COVID-19 pandemic:
A cross-sectional study of data from 105 countries. Tobacco Induced Diseases 21:January, pages 1-10.
Crossref
Crossref
Christopher Coe, Arpan Patel & David Lawrence. (2023) Pharmacotherapy options for alcohol use disorder in patients with alcohol-associated liver disease: a brief guide for clinicians. Clinical Liver Disease 21:5, pages 125-129.
Crossref
Crossref
Xiaofeng Liu, Shuzhen Yu, Yao Zhang, Wei Zhang, Hao Zhong, Xiaoqin Lu & Rongfa Guan. (2023) A review on the protective effect of active components in Antrodia camphorata against alcoholic liver injury. Journal of Ethnopharmacology 300, pages 115740.
Crossref
Crossref
Florence Thibaut. (2022) Pharmacological Treatments for Compulsive Sexual Behaviors Among Offending Individuals. Current Addiction Reports 10:1, pages 52-59.
Crossref
Crossref
Pascal Valentin Fischler, Michael Soyka, Erich Seifritz & Jochen Mutschler. (2022) Off-label and investigational drugs in the treatment of alcohol use disorder: A critical review. Frontiers in Pharmacology 13.
Crossref
Crossref
Cristian Sandoval, Jorge Farías, Mauricio Zamorano & Christian Herrera. (2022) Vitamin Supplements as a Nutritional Strategy against Chronic Alcohol Consumption? An Updated Review. Antioxidants 11:3, pages 564.
Crossref
Crossref
Falk Kiefer, Sabine Hoffmann, Julia Arens, Martin Beutel, Oliver Bilke-Hentsch, Gallus Bischof, Udo Bonnet, Jan Malte Bumb, Ralf Demmel, Silke Diestelkamp, Patric Driessen, Isabel Englert, Ursula Fennen, Heribert Fleischmann, Jennis Freyer-Adam, Wilma Funke, Dieter Geyer, Euphrosyne Gouzoulis-Mayfrank, Renate Hannak-Zeltner, Barbara Hansen, Ursula Havemann-Reinecke, Derik Hermann, Eva Hoch, Werner Höhl, Susann Hößelbarth, Kristin Hupfer, Julia Jückstock, Marianne Klein, Andreas Koch, Joachim Köhler, Michael Köhnke, Anne Koopmann, Oliver Kreh, Monika Krönes, Dietmar Kramer, Georg Kremer, Timo Krüger, Nikolaus Lange, Bodo Lieb, Johannes Lindenmeyer, Mathias Luderer, Karl Mann, Peter Missel, Sebastian Mueller, Michael Müller-Mohnssen, Corinna Nels-Lindemann, Tim Neumann, Thomas Polak, Ulrich W. Preuss, Olaf Reis, Gerhard Reymann, Monika Ridinger, Hans-Jürgen Rumpf, Peter-Michael Sack, Ingo Schäfer, Martin Schäfer, Norbert Scherbaum, Ariane Schulte, Welf Schroeder, Manfred Singer, Michael Soyka, Rainer Thomasius, Clemens Veltrup, Monika Vogelgesang, Irmgard Vogt, Marc Walter, Tillmann Weber, Georg Weil, Bernd Wessel, Tina Wessels, Klaudia Winkler, Nadja Wirth, Arnold Wieczorek, Norbert Wodarz & Dirk Wolter. 2022. S3-Leitlinie Screening, Diagnose und Behandlung alkoholbezogener Störungen. S3-Leitlinie Screening, Diagnose und Behandlung alkoholbezogener Störungen
51
356
.
Carol S. North & Fatih Canan. 2022. Textbook of Polytrauma Management. Textbook of Polytrauma Management
641
659
.
Johannes M. Hennings. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1523
1536
.
Tetsuji Cho. 2022. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
2525
2534
.
Ray Alsuhaibani, Douglas Cary Smith, Richard Lowrie, Sumayah Aljhani & Vibhu Paudyal. (2021) Scope, quality and inclusivity of international clinical guidelines on mental health and substance abuse in relation to dual diagnosis, social and community outcomes: a systematic review. BMC Psychiatry 21:1.
Crossref
Crossref
John D. Roache, Martina Pavlicova, Aimee Campbell, Tse‐Hwei Choo, Michelle Peavy, Andrea S. Kermack, Edward V. NunesJrJr & John Rotrosen. (2021) Is extended release naltrexone superior to buprenorphine‐naloxone to reduce drinking among outpatients receiving treatment for opioid use disorder? A secondary analysis of the CTN X:BOT trial. Alcoholism: Clinical and Experimental Research 45:12, pages 2569-2578.
Crossref
Crossref
Yunyun Liu, Jiande Li, Huanhuan Bu, Hongxuan Wang, Yuanpei Zhang, Qingyu Shen, Mei Li, Zijing Lu, Xiaoming Rong, Dong Zheng & Ying Peng. (2021) Circular RNA expression alteration identifies a novel circulating biomarker in serum exosomal for detection of alcohol dependence. Addiction Biology 26:6.
Crossref
Crossref
Mariangela Antonelli, Liana Fattore, Luisa Sestito, Daniela Di Giuda, Marco Diana & Giovanni Addolorato. (2021) Transcranial Magnetic Stimulation: A review about its efficacy in the treatment of alcohol, tobacco and cocaine addiction. Addictive Behaviors 114, pages 106760.
Crossref
Crossref
Saeed Kadasah, Ahmad Saleh Al Eid, Salem Saleh Alawad, Abdullah S. Al Shahrani, Ahmed Salem Alruwaihi, Ibrahim Elfaki & Mohammed Arshaduddin. (2021) Gastro protecting influence of Topiramate in ethanol produced gastric ulcers in rats. Toxicology Reports 8, pages 1031-1039.
Crossref
Crossref
Bharath Holla, Jitendriya Biswal, Vinutha Ramesh, Venkataram Shivakumar, Rose Dawn Bharath, Vivek Benegal, Ganesan Venkatasubramanian, Prabhat Kumar Chand & Pratima Murthy. (2020) Effect of prefrontal tDCS on resting brain fMRI graph measures in Alcohol Use Disorders: A randomized, double-blind, sham-controlled study.. Progress in Neuro-Psychopharmacology and Biological Psychiatry 102, pages 109950.
Crossref
Crossref
. (2020) The ASAM Clinical Practice Guideline on Alcohol Withdrawal Management. Journal of Addiction Medicine 14:3S, pages 1-72.
Crossref
Crossref
Laura Collet, Michaël Bisch, Sarah Viennet, Raymund Schwan & François Paille. (2020) Thiamine et trouble de l’usage d’alcool : une enquête de pratique nationale. Therapies 75:3, pages 281-294.
Crossref
Crossref
Octavian Vasiliu, Ileana Marinescu & Daniel Vasile. (2020) Therapeutic management of substance use disorders (II). Psihiatru.ro 1:60, pages 14.
Crossref
Crossref
Johannes M. Hennings. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
14
.
Tetsuji Cho. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
10
.
Tetsuji Cho. 2020. NeuroPsychopharmacotherapy. NeuroPsychopharmacotherapy
1
10
.
Justin Knox, Deborah S Hasin, Farren R R Larson & Henry R Kranzler. (2019) Prevention, screening, and treatment for heavy drinking and alcohol use disorder. The Lancet Psychiatry 6:12, pages 1054-1067.
Crossref
Crossref
Wim van den Brink. (2019) Baclofen: A Game Changer in the Treatment of Alcohol Dependence. Alcohol and Alcoholism.
Crossref
Crossref
Bernadett I. Gál, Tünde Kilencz, Anita Albert, Ildikó Demeter, Klára Mária Hegedűs, Zoltán Janka, Gábor Csifcsák & Péter Z. Álmos. (2019) Mild Effect of Nalmefene on Alcoholic Cue-Induced Response Invigoration in Alcohol Use Disorder Without Accompanying Changes in Electrophysiological Signatures of Early Visual Processing and Executive Control. Frontiers in Pharmacology 10.
Crossref
Crossref
K. Witkiewitz, R. Z. LittenL. Leggio. (2019) Advances in the science and treatment of alcohol use disorder. Science Advances 5:9.
Crossref
Crossref
Tsutomu Kurata, Tasuku Hashimoto & Hitoshi Suzuki. (2019) Concurrent, successful management of bipolar I disorder with comorbid alcohol dependence via aripiprazole long‐acting injection: A case report. Neuropsychopharmacology Reports 39:3, pages 238-240.
Crossref
Crossref
Andre F Carvalho, Markus Heilig, Augusto Perez, Charlotte Probst & Jürgen Rehm. (2019) Alcohol use disorders. The Lancet 394:10200, pages 781-792.
Crossref
Crossref
Bertha F. Polegato, Amanda G. Pereira, Paula S. Azevedo, Nara A. Costa, Leonardo A. M. Zornoff, Sergio A. R. Paiva & Marcos F. Minicucci. (2019) Role of Thiamin in Health and Disease. Nutrition in Clinical Practice 34:4, pages 558-564.
Crossref
Crossref
M Claire Greene, Jeremy Kane, Renee M Johnson & Wietse A Tol. (2019) Psychosocial and pharmacologic interventions to reduce harmful alcohol use in low- and middle-income countries. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Katrine Melby, Rolf W. Gråwe, Trond O. Aamo, Øyvind Salvesen & Olav Spigset. (2019) Effect of intranasal oxytocin on alcohol withdrawal syndrome: A randomized placebo-controlled double-blind clinical trial. Drug and Alcohol Dependence 197, pages 95-101.
Crossref
Crossref
Przemyslaw Bienkowski, Marcin Wojnar, Pawel Mierzejewski, Jerzy Samochowiec, Boguslaw Habrat, Marek Jarema & Janusz Rybakowski. (2019) Long-term pharmacotherapy aimed at maintaining abstinence or reducing alcohol intake in alcohol-dependent individuals. Guidelines from the Section of Pharmacotherapy of Polish Society for Research on Addictions (PTBU) and the Section of Psychopharmacology of Polish Psychiatric Association (PTP) – 2019 update. Pharmacotherapy in Psychiatry and Neurology 35:2, pages 95-110.
Crossref
Crossref
Fabio Caputo, Roberta Agabio, Teo Vignoli, Valentino Patussi, Tiziana Fanucchi, Paolo Cimarosti, Cristina Meneguzzi, Giovanni Greco, Raffaella Rossin, Michele Parisi, Davide Mioni, Sarino Arico’, Vincenzo Ostilio Palmieri, Valeria Zavan, Pierluigi Allosio, Patrizia Balbinot, Maria Francesca Amendola, Livia Macciò, Doda Renzetti, Emanuele Scafato & Gianni Testino. (2018) Diagnosis and treatment of acute alcohol intoxication and alcohol withdrawal syndrome: position paper of the Italian Society on Alcohol. Internal and Emergency Medicine 14:1, pages 143-160.
Crossref
Crossref
Daniel James Lim, Yogesh Sharma & Campbell Henry Thompson. (2018) Vitamin C and alcohol: a call to action. BMJ Nutrition, Prevention & Health 1:1, pages 17-22.
Crossref
Crossref
Roberta Agabio, Julia MA Sinclair, Giovanni Addolorato, Henri-Jean Aubin, Esther M Beraha, Fabio Caputo, Jonathan D Chick, Patrick de La Selle, Nicolas Franchitto, James C Garbutt, Paul S Haber, Mathis Heydtmann, Philippe Jaury, Anne R Lingford-Hughes, Kirsten C Morley, Christian A Müller, Lynn Owens, Adam Pastor, Louise M Paterson, Fanny Pélissier, Benjamin Rolland, Amanda Stafford, Andrew Thompson, Wim van den Brink, Renaud de Beaurepaire & Lorenzo Leggio. (2018) Baclofen for the treatment of alcohol use disorder: the Cagliari Statement. The Lancet Psychiatry 5:12, pages 957-960.
Crossref
Crossref
Roberta Agabio & Lorenzo Leggio. (2018) Baclofen in the Treatment of Patients With Alcohol Use Disorder and Other Mental Health Disorders. Frontiers in Psychiatry 9.
Crossref
Crossref
Lakshmi N Yatham, Sidney H Kennedy, Sagar V Parikh, Ayal Schaffer, David J Bond, Benicio N Frey, Verinder Sharma, Benjamin I Goldstein, Soham Rej, Serge Beaulieu, Martin Alda, Glenda MacQueen, Roumen V Milev, Arun Ravindran, Claire O'Donovan, Diane McIntosh, Raymond W Lam, Gustavo Vazquez, Flavio Kapczinski, Roger S McIntyre, Jan Kozicky, Shigenobu Kanba, Beny Lafer, Trisha Suppes, Joseph R Calabrese, Eduard Vieta, Gin Malhi, Robert M Post & Michael Berk. (2018) Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disorders 20:2, pages 97-170.
Crossref
Crossref
Clément Palpacuer, Renan Duprez, Alexandre Huneau, Clara Locher, Rémy Boussageon, Bruno Laviolle & Florian Naudet. (2018) Pharmacologically controlled drinking in the treatment of alcohol dependence or alcohol use disorders: a systematic review with direct and network meta-analyses on nalmefene, naltrexone, acamprosate, baclofen and topiramate. Addiction 113:2, pages 220-237.
Crossref
Crossref
Gemma Mestre-Bach, Trevor Steward, Susana Jiménez-Murcia & Fernando Fernández-Aranda. (2017) Differences and Similarities Between Compulsive Buying and Other Addictive Behaviors. Current Addiction Reports 4:3, pages 228-236.
Crossref
Crossref
Andrew Naglich, Bryon Adinoff & E. Sherwood Brown. (2017) Pharmacological Treatment of Bipolar Disorder with Comorbid Alcohol Use Disorder. CNS Drugs 31:8, pages 665-674.
Crossref
Crossref
Tom MunyerAzita Alipour & Jessa M. Koch. 2017. PharmacotherapyFirst: A Multimedia Learning Resource. PharmacotherapyFirst: A Multimedia Learning Resource.